Jan Terje Andersen

7.5k total citations · 1 hit paper
102 papers, 4.7k citations indexed

About

Jan Terje Andersen is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Jan Terje Andersen has authored 102 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Radiology, Nuclear Medicine and Imaging, 60 papers in Molecular Biology and 30 papers in Immunology. Recurrent topics in Jan Terje Andersen's work include Monoclonal and Polyclonal Antibodies Research (72 papers), Glycosylation and Glycoproteins Research (40 papers) and Protein purification and stability (24 papers). Jan Terje Andersen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (72 papers), Glycosylation and Glycoproteins Research (40 papers) and Protein purification and stability (24 papers). Jan Terje Andersen collaborates with scholars based in Norway, United Kingdom and United States. Jan Terje Andersen's co-authors include Inger Sandlie, Kine Marita Knudsen Sand, Jeannette Nilsen, Malin Bern, Stian Foss, Richard S. Blumberg, Muluneh Bekele Daba, Terje E. Michaelsen, Algirdas Grevys and Leo C. James and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jan Terje Andersen

101 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Neonatal Fc Receptor (FcRn): A Misnomer?

2019 297 citations Michał Pyzik, Kine Marita Knudsen Sand et al. profile →

Peers

Countries citing papers authored by Jan Terje Andersen

Since Specialization

Citations

This map shows the geographic impact of Jan Terje Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Terje Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Terje Andersen more than expected).

Fields of papers citing papers by Jan Terje Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Terje Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Terje Andersen. The network helps show where Jan Terje Andersen may publish in the future.

Co-authorship network of co-authors of Jan Terje Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Terje Andersen. A scholar is included among the top collaborators of Jan Terje Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Terje Andersen. Jan Terje Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life 2025 ·PNAS Nexus ·(unknown), (unknown), (unknown), Stian Foss, J.H. Marco Jansen, (unknown), Mitchell Evers, Jeannette Nilsen, Karli R. Reiding, J Damen, Renate Burger, Algirdas Grevys, Bjørn Dalhus, Thomas Valerius, Inger Sandlie, Jeanette H.W. Leusen, Jan Terje Andersen	3
2	Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction 2025 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anaïs Jiménez-Reinoso, Marie B. Iversen, (unknown), Ryo Narita, Susana Frago, Kristine Raaby Jakobsen, Jan Terje Andersen, Søren E. Degn, Søren R. Paludan, Luis Álvarez‐Vallina, Kenneth A. Howard	0
3	Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress 2025 ·BioDrugs ·Torleif Tollefsrud Gjølberg, (unknown), (unknown), (unknown), Inger Sandlie, Jan Terje Andersen	3
4	Antibody blockade of Jagged1 attenuates choroidal neovascularization 2023 ·Nature Communications ·Torleif Tollefsrud Gjølberg, (unknown), (unknown), (unknown), Nicola Bassi, Panagiotis Christopoulos, Malin Bern, Stian Foss, Goran Petrovski, Morten C. Moe, Guttorm Haraldsen, Johanna Hol Fosse, Bjørn Steen Skålhegg, Jan Terje Andersen, Eirik Sundlisæter	9
5	A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery 2023 ·PNAS Nexus ·(unknown), (unknown), Anette Kolderup, Marina Vaysburd, (unknown), Donna L. Mallery, Even Fossum, (unknown), Anna Albecka, Aleksandr Ianevski, Denis E. Kainov, Karine Flem‐Karlsen, (unknown), (unknown), Torleif Tollefsrud Gjølberg, Morten C. Moe, Magnar Bjørås, Inger Sandlie, Leo C. James, Jan Terje Andersen	5
6	Phage display assisted discovery of a pH ‐dependent anti‐α‐cobratoxin antibody from a natural variable domain library 2023 ·Protein Science ·(unknown), (unknown), Charlotte Rimbault, Shirin Ahmadi, Esperanza Rivera‐de‐Torre, Monica L. Fernández‐Quintero, Johannes R. Loeffler, Markus‐Frederik Bohn, Anne Ljungars, Line Ledsgaard, Björn G. Voldborg, (unknown), Jan Terje Andersen, Andreas H. Laustsen	7
7	Assessing developability early in the discovery process for novel biologics 2023 ·mAbs ·Monica L. Fernández‐Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy P. Jenkins, Björn G. Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty, Andreas H. Laustsen	51
8	Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge 2022 ·Science Immunology ·Stian Foss, (unknown), Maria Bottermann, Ruth Watkinson, (unknown), (unknown), Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	20
9	Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life 2022 ·Communications Biology ·Torleif Tollefsrud Gjølberg, Rahel Frick, (unknown), Stian Foss, Algirdas Grevys, Lene S. Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe, Jan Terje Andersen	14
10	Contribution of the ex vivo placental perfusion model in understanding transplacental immunoglobulin G transfer 2022 ·Placenta ·Kine Marita Knudsen Sand, Michael Gruber, Inger Sandlie, Line Mathiesen, Jan Terje Andersen, Christian Wadsack	4
11	Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies 2022 ·mAbs ·Rahmad Akbar, (unknown), Puneet Rawat, Philippe A. Robert, Eva Smorodina, (unknown), Karine Flem‐Karlsen, (unknown), Brij Bhushan Mehta, (unknown), (unknown), Jose Gutierrez‐Marcos, Fridtjof Lund‐Johansen, Jan Terje Andersen, Victor Greiff	73
12	In silico proof of principle of machine learning-based antibody design at unconstrained scale 2022 ·mAbs ·Rahmad Akbar, Philippe A. Robert, Cédric R. Weber, Michael Widrich, (unknown), Milena Pavlović, Lonneke Scheffer, Maria Chernigovskaya, Igor Snapkov, Andrei Slabodkin, Brij Bhushan Mehta, Enkelejda Miho, Fridtjof Lund‐Johansen, Jan Terje Andersen, Sepp Hochreiter, Ingrid Hobæk Haff, Günter Klambauer, Geir Kjetil Sandve, Victor Greiff	50
13	Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity 2021 ·Communications Biology ·(unknown), (unknown), Simón Lykkemark, (unknown), Imke Rudnik‐Jansen, (unknown), Jan Terje Andersen, Luis Álvarez‐Vallina, Kenneth A. Howard	43
14	Platelets mediate serological memory to neutralize viruses in vitro and in vivo 2020 ·Blood Advances ·Waltraud C. Schrottmaier, Manuel Salzmann, Sigrun Badrnya, Marion Mußbacher, Julia B. Kral‐Pointner, (unknown), (unknown), (unknown), Koon-Chu Yaiw, (unknown), David Pereyra, Jan Terje Andersen, Andreas Bergthaler, Cecilia Söderberg‐Nauclér, Mikael C. I. Karlsson, Alice Assinger, Mattias N.E. Forsell	9
15	FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity 2020 ·The Journal of Experimental Medicine ·Jonathan J. Hubbard, Michał Pyzik, Timo Räth, Lisa K. Kozicky, Kine Marita Knudsen Sand, Amit Gandhi, Algirdas Grevys, Stian Foss, (unknown), Jonathan N. Glickman, Edda Fiebiger, Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen, Laura M. Sly, Kristi Baker, Richard S. Blumberg	34
16	NHDL, a recombinant V _L /V _H hybrid antibody control for IgG2/4 antibodies 2019 ·mAbs ·Corinna Lau, (unknown), Grethe Bergseth, Algirdas Grevys, Jack‐Ansgar Bruun, Judith Krey Ludviksen, Hilde Fure, Terje Espevik, Anders Moen, Jan Terje Andersen, Tom Eirik Mollnes	3
17	TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity 2016 ·The Journal of Immunology ·Stian Foss, Ruth Watkinson, Algirdas Grevys, (unknown), Malin Bern, Lene S. Høydahl, Bjørn Dalhus, Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	34
18	Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization 2015 ·Journal of Controlled Release ·Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Patricia A. Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie, Jan Terje Andersen	23
19	A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance 2012 ·Protein Engineering Design and Selection ·Paul J. Yazaki, (unknown), Divya Channappa, Chi Wai Cheung, Desiree Crow, Junie Chea, Erasmus Poku, (unknown), Jan Terje Andersen, Inger Sandlie, Kelly Davis Orcutt, K. Dane Wittrup, John E. Shively, Andrew Raubitschek, David Colcher	29
20	Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8 ⁻ CD11b ⁺ dendritic cells 2011 ·Proceedings of the National Academy of Sciences ·Kristi Baker, Shuo‐Wang Qiao, Timothy Kuo, Victoria G. Aveson, Barbara Platzer, Jan Terje Andersen, Inger Sandlie, Zhangguo Chen, Colin de Haar, Wayne I. Lencer, Edda Fiebiger, Richard S. Blumberg	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact